Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.72 |
| ▸ | FAAH | O00519 | 6/20 | 0.66 |
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6930931 | 1.00 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL2458053 | 1.00 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL9549424 | 0.96 | DNM1 (0.77) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL24728718 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL3853645 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL8399025 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL8397761 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL8394133 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL11440198 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA | |
| SCHEMBL8394200 | 0.93 | DNM1 (0.72) | DNM1FAAHCASP2SELPNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042955-A1 | VISCOELASTIC FOAM SYSTEM FOR ACIDIC GAS SWITCH, AND METHOD AND USE FOR IMPROVING THE RECOVERY FACTOR USING THE SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2026-02-12 | — | — | US | disclosed |
| EP-4545619-A1 | VISCOELASTIC FOAM SYSTEM OF ACID GAS SWITCH, AND METHOD AND USE FOR IMPROVING RECOVERY RATIO BY USING VISCOELASTIC FOAM SYSTEM | China Petroleum & Chemical Corporation (CN) | 2025-04-30 | — | — | EP | disclosed |
| WO-2024002048-A1 | VISCOELASTIC FOAM SYSTEM OF ACID GAS SWITCH, AND METHOD AND USE FOR IMPROVING RECOVERY RATIO BY USING VISCOELASTIC FOAM SYSTEM | 中国石油化工股份有限公司 | 2024-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042955-A1 | VISCOELASTIC FOAM SYSTEM FOR ACIDIC GAS SWITCH, AND METHOD AND USE FOR IMPROVING THE RECOVERY FACTOR USING THE SAME | PIEZO1, SGMS1, SGMS2 | DNM1 1572/4885FAAH 499/4885CASP2 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.